Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 12:03 AM
NCT ID:
NCT03519958
Eligibility Criteria:
Inclusion Criteria
* Provision of written informed consent
* Locally advanced (stage IIIB) or metastatic (stage IV) NSCLC, not amenable to curative surgery or radiotherapy
* Confirmed EGFR sensitizing mutation (exon 19 deletion or exon 21 L858R ) in medical record
* Progressed on previous EGFR TKI treatment, based on physician judgement, with or without additional lines of treatment
* Suggested to undergo T790M mutation testing by treating physician, based on physician judgement
Exclusion Criteria
* Had been treated with osimertinib or any other 3rd generation T790M inhibitors
* Enrollment in studies that prohibit participation in this observational study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT03519958
Study Brief:
Protocol Section:
NCT03519958